AR-12

2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide · Arno Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AR-12, covering 2014-01-29 to 2014-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma [Phase 1]

See pricing